newsfilter
← Latest News
GlobeNewswire·

Chimerix to Participate in Upcoming Investor Conferences

DURHAM, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly